Darren Incorvaia

Darren Incorvaia, an experienced biotech reporter and analyst, dives into the haunting tales of the 2025 Biotech Graveyard. He discusses the shocking rise in cell therapy failures, spotlighting the chaotic saga of Charisma and the remarkable comeback of Vorbio. The conversation reveals insights on macro headwinds affecting biotech, innovative 'mad science' startups, and the ongoing struggle for funding in a post-COVID landscape. Through a mix of humor and analysis, Darren sheds light on the industry's uncertain future and the strategies being employed to navigate these turbulent waters.